19
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Clinical therapeutic evaluation of methylcysteine hydrochloride in patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control

, , , , , & show all
Pages 461-471 | Received 02 May 1978, Published online: 11 Aug 2008

References

  • Aylward M. A between-patient, double-blind comparison of S-carboxymethylcysteine and bromhexine in chronic obstructive bronchitis. Curr. Med. Res. Opin. 1973; 1: 2191. Aylward M. A between-patient, double-blind comparison of S-carboxymethylcysteine and bromhexine in chronic obstructive bronchitis. Curr. Med. Res. Opin. 1973; 1: 219
  • Hamilton W. F. D., Palmer K. N. V., Gent M. Expectorant action of bromhexine in chronic obstructive bronchitis. Br. Med. J. 1970; 3: 2602. Hamilton W. F. D., Palmer K. N. V., Gent M. Expectorant action of bromhexine in chronic obstructive bronchitis. Br. Med. J. 1970; 3: 260
  • Havez R., Degand P., Roussel P., Randoux A. Mode d'action biochemique des dérivés de la cystéine sur le mucus bronchique. Poumon Coeur 1970; 26: 813. Havez R., Degand P., Roussel P., Randoux A. Mode d'action biochemique des dérivés de la cystéine sur le mucus bronchique. Poumon Coeur 1970; 26: 81
  • Keal E., Reid L. Neuraminic acid content of sputum in chronic bronchitis. Thorax 1972; 27: 6434. Keal E., Reid L. Neuraminic acid content of sputum in chronic bronchitis. Thorax 1972; 27: 643
  • Lopez-Vidriero M. T., Charman J., Keal E., De Silva D. J., Reid L. Sputum viscosity: correlation with chemical and clinical features in chronic bronchitis. Thorax 1973; 28: 4015. Lopez-Vidriero M. T., Charman J., Keal E., De Silva D. J., Reid L. Sputum viscosity: correlation with chemical and clinical features in chronic bronchitis. Thorax 1973; 28: 401
  • Medical Research Council. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet 1965; 1: 7756. Medical Research Council. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet 1965; 1: 775

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.